Intrauterine transfusion, non-immune fetal hydrops
Case report
DOI:
https://doi.org/10.29193/RMU.40.2.6Keywords:
FETAL ANEMIA, HIDROPS FETALIS, CORDOCENTESIS, INTRAUTERINE TRANSFUSIONAbstract
Introduction: fetal hydrops is a serious condition with a poor prognosis and high morbidity and mortality, despite improvements in diagnostics and therapeutics in recent years. Prognosis is determined by the etiology and therapeutic options associated with better outcomes, gestational age, diagnosis, and birth, although it should be noted that there are not enough long-term follow-up studies.
Ultrasound diagnosis is confirmatory, with the main challenge being to identify the etiology and propose the appropriate therapeutic strategy.
Description of the case: we present a patient diagnosed with non-immune fetal hydrops and its therapeutic approach. The cause of hydrops was severe fetal anemia, requiring 3 procedures with intrauterine partial exsanguination transfusion through Cordocentesis. At 33 weeks, the decision was made to terminate the pregnancy, with good neonatal outcomes.
Conclusions: fetal hydrops increases fetal and neonatal morbidity and mortality, posing a significant challenge for the treating team and requiring an interdisciplinary healthcare team. Understanding this condition allows for a comprehensive approach, guiding the etiology, providing timely diagnosis, and selecting appropriate treatment. As in this case, identifying severe anemia as the cause of hydrops mandates defining the management for fetuses eligible for intrauterine therapy.
References
Hospital Clínic de Barcelona, Hospital Sant Joan de Déu, Universitat de Barcelona; Borobio V, Sabriá J, Goncé A. Protocolo: hidrops fetal no inmune. Barcelona: Hospital Clínic, 2021.
Society for Maternal-Fetal Medicine; Norton ME, Chauhan SP, Dashe JS. Society for maternal-fetal medicine (SMFM) clinical guideline #7: nonimmune hydrops fetalis. Am J Obstet Gynecol 2015; 212(2):127-39. doi: 10.1016/j.ajog.2014.12.018.
Bellini C, Donarini G, Paladini D, Calevo MG, Bellini T, Ramenghi LA, et al. Etiology of non-immune hydrops fetalis: an update. Am J Med Genet A 2015; 167A(5):1082-8. doi: 10.1002/ajmg.a.36988.
Meng D, Li Q, Hu X, Wang L, Tan S, Su J, et al. Etiology and outcome of nonimmune hydrops fetalis in southern China: report of 1004 cases. Sci Rep 2019; 9(1):10726. doi: 10.1038/s41598-019-47050-6.
Cafici D, Sepúlveda W. Hidrops fetal e hidrotorax fetal. En: Cafici D, Sepúlveda W. Ultrasonografía en obstetricia y diagnóstico prenatal. 2ª ed. Buenos Aires: Ed. Journal, 2018:529-40.
Randenberg AL. Nonimmune hydrops fetalis part II: does etiology influence mortality? Neonatal Netw 2010; 29(6):367-80. doi: 10.1891/0730-0832.29.6.367.
Désilets V, Audibert F; Society of Obstetrician and Gynaecologists of Canada. RETIRED: Investigation and management of non-immune fetal hydrops. J Obstet Gynaecol Can 2013; 35(10):923-38.
Bhide A, Acharya G, Bilardo CM, Brezinka C, Cafici D, Hernandez-Andrade E, et al. SUOG practice guidelines: use of Doppler ultrasonography in obstetrics. Ultrasound Obstet Gynecol 2013; 41(2):233-9. doi: 10.1002/uog.12371.
De Agostini M, González Rocha J. Guías para la aplicación clínica del ultrasonido obstétrico y ginecológico. SEGU 2020:144-58. Disponible en:https://www.ginecotocologicab.hc.edu.uy/images/GUIA_ULTRASONIDO-OBSTETRICO_Y_GINECOLOGICO-URUFARMA_2020.pdf (Consulta: 3 noviembre 2023).
FetalTest.com, Medicina Fetal On Line. Programa informático para la evaluación de la anemia fetal en función de la velocidad máxima de la arteria cerebral media. Disponible en: http://fetaltest.com/cgi-bin/acmtest.cgi (Consulta: 24 setiembre 2023).
Bianchi M, Vaglio S, Pupella S, Marano G, Facco G, Liumbruno GM, et al. Leucoreduction of blood components: an effective way to increase blood safety? Blood Transfus 2016; 14(2):214-27. doi: 10.2450/2015.0154-15.
Hospital Clínic, Hospital Sant Joan de Déu, Universitat de Barcelona; Borrell A, Borobio V, Sabrià J, Miró I. Guía Clínica: Amniocentesis. Barcelona: Hospital Clínic, 2018:5-9.
Unidad Clínica de Diagnóstico Prenatal, Área de Medicina Fetal, Servei de Medicina Materno-Fetal, Institut Clínic de Ginecologia, Obstetrícia y Neonatologia, Hospital Clínic de Barcelona; Borrell A. Guía Clínica: Cordocentesis. Barcelona: Hospital Clínic, 2010:2 p.
Martínez-Portilla RJ, López-Félix J, Hawkins-Villareal A, Villafán-Bernal JR, Paz Y Miño F, Figueras F, et al. Performance of middle cerebral artery peak systolic velocity for the prediction of fetal anemia in untransfused and transfused fetuses: a diagnostic test accuracy meta-analysis. Ultrasound Obstet Gynecol 2019; 54(6):722-31. doi: 10.1002/uog.20273.
Zwiers C, Lindenburg ITM, Klumper FJ, de Haas M, Oepkes D, Van Kamp IL. Complications of intrauterine intravascular blood transfusion: lessons learned after 1678 procedures. Ultrasound Obstet Gynecol 2017; 50(2):180-6. doi: 10.1002/uog.17319.
Borrell A. Anemia y trombocitopenia fetal. En: Figueras F, Gratacós E, Gómez-Roig MD, Martínez Crespo JM, Palacio M. Actualización en medicina maternofetal: contenido teórico del curso intensivo en medicina maternofetal. 4ªed. 2021:460-82.
Disponible en: https://www.dirzon.com/file/telegram/librosmedicos_cubanos/Medicina_Maternofetal_Figueras_Gratac%C3%B3s_Roig_4ta_Ed_Espa%C3%B1a_2021.pdf (Consulta: 24 setiembre 2023).
New HV, Berryman J, Bolton-Maggs PH, Cantwell C, Chalmers EA, Davies T, et al. Guidelines on transfusion for fetuses, neonates and older children. Br J Haematol 2016; 175(5):784-828. doi: 10.1111/bjh.14233.
Lindenburg IT, van Kamp IL, Oepkes D. Intrauterine blood transfusion: current indications and associated risks. Fetal Diagn Ther 2014; 36(4):263-71. doi: 10.1159/000362812.
Society for Maternal-Fetal Medicine; Berry SM, Stone J, Norton ME, Johnson D, Berghella V. Fetal blood sampling. Am J Obstet Gynecol 2013; 209(3):170-80. doi: 10.1016/j.ajog.2013.07.014.
Van Kamp IL, Klumper FJ, Oepkes D, Meerman RH, Scherjon SA, Vandenbussche FP, et al. Complications of intrauterine intravascular transfusion for fetal anemia due to maternal red-cell alloimmunization. Am J Obstet Gynecol 2005; 192(1):171-7. doi: 10.1016/j.ajog.2004.06.063.
Decreto N° 385/000. Aprobación del Reglamento Técnico Mercosur de Medicina Transfusional. Resolución GMC 42/00. Montevideo, 9 de enero de 2001. Montevideo, IMPO, 2001. Disponible en: https://www.impo.com.uy/bases/decretos/385-2000 (Consulta: 19 enero 2024).
Clarke G. Intrauterine transfusion: an international review of practice and policy. ISBT Sci Ser 2020; 15(3):342-6. doi: 10.1111/voxs.12552.
Mari G, Norton ME, Stone J, Berghella V, Sciscione AC, Tate D, et al. Clinical Guideline #8: the fetus at risk for anemia--diagnosis and management. Am J Obstet Gynecol 2015 ;212(6):697-710. doi: 10.1016/j.ajog.2015.01.059.
Abbasi N, Johnson JA, Ryan G. Fetal anemia. Ultrasound Obstet Gynecol 2017; 50(2):145-53. doi: 10.1002/uog.17555.
Detti L, Oz U, Guney I, Ferguson JE, Bahado-Singh RO, Mari G; Collaborative Group for Doppler Assessment of the Blood Velocity in Anemic Fetuses. Doppler ultrasound velocimetry for timing the second intrauterine transfusion in fetuses with anemia from red cell alloimmunization. Am J Obstet Gynecol 2001; 185(5):1048-51. doi: 10.1067/mob.2001.118161.
Moise KJ Jr. The usefulness of middle cerebral artery Doppler assessment in the treatment of the fetus at risk for anemia. Am J Obstet Gynecol 2008; 198(2):161.e1-4. doi: 10.1016/j.ajog.2007.10.788.
Prefumo F, Fichera A, Fratelli N, Sartori E. Fetal anemia: diagnosis and management. Best Pract Res Clin Obstet Gynaecol 2019; 58:2-14. doi: 10.1016/j.bpobgyn.2019.01.001.
Amann C, Geipel A, Müller A, Heep A, Ritgen J, Stressig R, et al. Fetal anemia of unknown cause--a diagnostic challenge. Ultraschall Med 2011; 32(Suppl 2):E134-40. doi: 10.1055/s-0031-1281756.
Chinelo OV, Elendu Ch, Ifeoma AC, Umeh I, Okoro Ch, Peterson J. Causes of anemia due to diminished red blood cell production in pediatrics. Int J Sci Adv 2022; 3(5):711-8. doi: 10.51542/ijscia.v3i5.6.
Manuck TA, Rice MM, Bailit JL, Grobman WA, Reddy UM, Wapner RJ, et al. Preterm neonatal morbidity and mortality by gestational age: a contemporary cohort. Am J Obstet Gynecol 2016; 215(1):103.e1-103.e14. doi: 10.1016/j.ajog.2016.01.004.
